Pharmaids Pharmaceuticals (BOM:524572) Shares Outstanding (Basic Average): 35.0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:524572 Pharmaids Pharmaceuticals Ltd BOM:524572
23 GF Score
Price ₹31.32
! 3 Warning Signs
View Full Analysis

What is Pharmaids Pharmaceuticals Shares Outstanding (Basic Average)?

Pharmaids Pharmaceuticals BOM:524572 +1.89% 23 Shares Outstanding (Basic Average) is 35.0 Mil as of Jun. 2026. GuruFocus rates BOM:524572 with a GF Score™ of 23/100. The stock has 3 warning signs investors should review.

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Pharmaids Pharmaceuticals's average basic shares outstanding for the quarter that ended in Jun. 2026 was 35.0 Mil.


Pharmaids Pharmaceuticals  (BOM:524572) Shares Outstanding (Basic Average) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.


Be Aware

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Pharmaids Pharmaceuticals Shares Outstanding (Basic Average) Related Terms


Pharmaids Pharmaceuticals Shares Outstanding (Basic Average) Historical Data

* Premium members only.

The historical data trend for Pharmaids Pharmaceuticals's Shares Outstanding (Basic Average) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharmaids Pharmaceuticals Shares Outstanding (Basic Average) Chart

Pharmaids Pharmaceuticals Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Shares Outstanding (Basic Average)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.31 12.90 22.72 35.33 35.40

Pharmaids Pharmaceuticals Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Shares Outstanding (Basic Average) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 35.12 35.43 35.41 35.47 35.01
BOM:524572
23GF Score
Pharmaids Pharmaceuticals Ltd BOM:524572
Shares Outstanding (Basic Average) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pharmaids Pharmaceuticals Shares Outstanding (Basic Average) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that exact time point. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.

What does a Shares Outstanding (Basic Average) of 35.0 Mil mean?
Pharmaids Pharmaceuticals (BOM:524572) has a Shares Outstanding (Basic Average) of 35.0 Mil as of Jun. 2026. The average shares outstanding over two periods not accounting for dilutive securities like convertible bonds. View historical data on Pharmaids Pharmaceuticals and its competitors.
Is Pharmaids Pharmaceuticals' Shares Outstanding (Basic Average) too high?
Pharmaids Pharmaceuticals' current Shares Outstanding (Basic Average) is 35.0 Mil. Overall, Pharmaids Pharmaceuticals has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Pharmaids Pharmaceuticals' Shares Outstanding (Basic Average) compare to ZTS?
Pharmaids Pharmaceuticals' Shares Outstanding (Basic Average) of 35.0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Outstanding (Basic Average) for a Drug Manufacturers company?
A good Shares Outstanding (Basic Average) depends on the Drug Manufacturers industry context. However, Shares Outstanding (Basic Average) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Outstanding (Basic Average) mean?
A high Shares Outstanding (Basic Average) can signal that a stock is expensive relative to its fundamentals. The average shares outstanding over two periods not accounting for dilutive securities like convertible bonds. View historical data on Pharmaids Pharmaceuticals and its competitors. Pharmaids Pharmaceuticals's current Shares Outstanding (Basic Average) is 35.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharmaids Pharmaceuticals stock overvalued right now?
Pharmaids Pharmaceuticals (BOM:524572) has a current Shares Outstanding (Basic Average) of 35.0 Mil. The current Shares Outstanding (Basic Average) is 35.0 Mil. Pharmaids Pharmaceuticals' overall GF Score™ is 23/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Outstanding (Basic Average) calculated?
Shares Outstanding (Basic Average) is calculated from a company's financial statements. For Pharmaids Pharmaceuticals (BOM:524572), the current Shares Outstanding (Basic Average) is 35.0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Pharmaids Pharmaceuticals Business Description

Address HMT Factory Road, Unit 201, Brigade Rubix, 20/14, Peenya Plantation, Bangalore, KA, IND, 560013
Pharmaids Pharmaceuticals Ltd is an Indian pharmaceutical company that manufactures specialty chemicals, skin care products, hospital care products, and generic drugs. Its product range includes vitamins and related compounds, hand sanitizers, antiseptic solutions, ointments, and various bulk drugs. The company operates from Hyderabad, India, serving domestic and select international markets. Pharmaids generates revenue prominently from the sale of these pharmaceutical and healthcare products. Its operations focus on manufacturing and supplying formulations across healthcare and personal care segments.
23GF Score

Get the complete analysis for BOM:524572

Shares Outstanding (Basic Average) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹31.32
Price